Received Apr 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y97N7 | — |
administration of Infanrix to a 74-year-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 74-year-old male patient who received DTPa (Infanrix) (batch number Y97N7, expiry date 31-AUG-2026) for prophylaxis. On 14-APR-2026, the patient received Infanrix. On 14-APR-2026, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administration of Infanrix to a 74-year-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-APR-2026 The health care professional asked for safety data and recommendation about revaccination.